Swedish Biotech Stock News

Despite posting strong earnings, Studentbostäder i Norden AB (publ)'s ( STO:STUDBO ) stock didn't move much over the...

Cibus Nordic Real Estate AB (publ) ( STO:CIBUS ) stock is about to trade ex-dividend in three days. The ex-dividend...

The Candles Scandinavia AB (publ) ( STO:CANDLE B ) share price has fared very poorly over the last month, falling by a...

The board of SkiStar AB (publ) ( STO:SKIS B ) has announced that it will be paying its dividend of SEK3.00 on the 19th...

Key Insights Gruvaktiebolaget Viscaria's significant retail investors ownership suggests that the key decisions are...

It hasn't been the best quarter for Hoist Finance AB (publ) ( STO:HOFI ) shareholders, since the share price has fallen...

Despite posting some strong earnings, the market for Titania Holding AB (publ)'s ( STO:TITA B ) stock hasn't moved...

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Synsam AB (publ) ( STO:SYNSAM ) just released its latest third-quarter results and things are looking bullish. It was...

With a price-to-sales (or "P/S") ratio of 1.2x Magle Chemoswed Holding AB (publ) ( STO:MAGLE ) may be sending bullish...

The board of Cedergrenska AB (publ) ( STO:CEDER ) has announced that it will pay a dividend on the 29th of December...

To the annoyance of some shareholders, Dometic Group AB (publ) ( STO:DOM ) shares are down a considerable 27% in the...

Insiders who bought QleanAir AB (publ) ( STO:QAIR ) in the last 12 months may probably not pay attention to the stock's...

With a median price-to-sales (or "P/S") ratio of close to 1.1x in the Insurance industry in Sweden, you could be...

When companies post strong earnings, the stock generally performs well, just like ByggPartner Gruppen AB (publ)'s...

Zinzino AB (publ) ( STO:ZZ B ) shareholders are no doubt pleased to see that the share price has bounced 36% in the...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Arlandastad Group AB (publ)'s ( STO:AGROUP ) robust recent earnings didn't do much to move the stock. We think this is...

In recent days, Essity announced the continuation of its SEK 3 billion share buyback program and entered a new partnership with NielsenIQ to serve as its primary provider for point-of-sale and consumer intelligence solutions across the United States. This move towards recurring share repurchases and enhanced data-driven decision-making highlights Essity's commitment to strengthening shareholder value and accelerating digital transformation in key markets. We'll look at how Essity's data...

Catena announced that it has secured two eight-year lease agreements with ICA Fastigheter AB for logistics facilities at its Helsingborg site, covering one existing property and a new, sustainably-built 18,042 m2 building to be completed by early 2027. This development reflects increased long-term occupancy and income certainty for Catena, while highlighting growing demand from major clients for sustainable and modern logistics solutions. To assess how Catena’s portfolio and income outlook...

Over the last year, a good number of insiders have significantly increased their holdings in Evolution AB (publ...

On November 6, 2025, Telia Company announced a four-year extension of its Radio Access Network partnership with Ericsson, covering Sweden, Norway, Lithuania, and Estonia to enhance network performance and deploy advanced 5G capabilities across multiple sectors. This expanded collaboration underscores Ericsson’s role in supporting mission-critical communications, 5G innovation, and digital infrastructure modernization for industries and public services throughout the Nordic and Baltic...

Earlier this month, Camurus announced positive topline results from a Phase 1b trial evaluating CAM2056, its monthly FluidCrystal® semaglutide formulation, which demonstrated significant dose-dependent reductions in body weight, hemoglobin A1c, and fasting glucose in people with overweight or obesity, with efficacy comparable to or greater than weekly semaglutide. This study suggests CAM2056 could offer similar or stronger metabolic benefits with the convenience of monthly dosing,...